Aleve Has A ‘Headache’ For Proprietary Brand And As First Indication On Labeled Uses List

US FDA approves Bayer HealthCare's supplemental NDA for adding Aleve Headache Pain proprietary name to use with the brand’s regular strength formulation, naproxen 220 mg. The approval also allows moving headache to top of indications list.

Nov 2, 2019 San Francisco / CA / USA - Bayer offices located in Mission Bay District; Bayer AG is a German multinational pharmaceutical and life sciences company, one of the largest in the world

More from Regulation

More from Policy & Regulation